Temoporfin
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Temoporfin
Description :
Temoporfin (m-THPC), a reduced porphyrin, is a potent second-generation photosensitizer. Temoporfin can be used in the research of photodynamic therapy (PDT) for head and neck cancers[1][2][3].CAS Number :
[122341-38-2]Product Name Alternative :
M-THPC; KW2345UNSPSC :
12352005Hazard Statement :
H301Target :
Reactive Oxygen Species (ROS)Type :
Reference compoundRelated Pathways :
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κBApplications :
Cancer-programmed cell deathField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/Temoporfin.htmlPurity :
97.34Solubility :
DMSO : 20.83 mg/mL (ultrasonic; warming; heat to 60°C)Smiles :
OC1=CC=CC(/C2=C3CCC(/C(C4=CC(O)=CC=C4)=C5C=C/C(N/5)=C(C6=CC(O)=CC=C6)/C(C=C/7)=NC7=C(C8=CC(O)=CC=C8)/C9=CC=C2N9)=N\3)=C1Molecular Formula :
C44H32N4O4Molecular Weight :
680.75Precautions :
H301References & Citations :
[2]Rovers JP, et, al. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra (hydroxyphenyl) chlorin (mTHPC), in a rat model. Br J Cancer. 1999 Oct;81 (4) :600-8. |[3]Reshetov V, et, al. Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin) : comparison of treatment efficacy and distribution characteristics in vivo. Int J Nanomedicine. 2013;8:3817-31. |[1]Senge MO, et, al. Temoporfin (Foscan®, 5,10,15,20-tetra (m-hydroxyphenyl) chlorin) --a second-generation photosensitizer. Photochem Photobiol. 2011 Nov-Dec;87 (6) :1240-96.Shipping Conditions :
Blue IceStorage Conditions :
-20°C (Powder, protect from light, stored under nitrogen)Scientific Category :
Reference compound1Clinical Information :
Launched

